Chinese Startups Claim Grapeseed Pill Can Extend Life to 150

As of November 10th, 2025, Chinese longevity startups are making significant strides in the race to extend human lifespan. Lonvi Biosciences, a company based in Shenzhen, has developed anti-aging pills using a compound found in grapeseed extract that they claim can increase the lifespan of mice by over 60%. The company's chief technology officer, Lyu Qinghua, boldly predicts that "in a few years, this will be the reality" for humans, with the potential to eliminate cancer within 5-10 years.

China's enthusiasm for longevity research has surged in recent years, driven by both state investment and growing public interest. Harvard professor Vadim Gladyshev notes that Chinese researchers "are rapidly catching up" to the West in this field, which was once dominated by "wild claims" that alienated many scientists. However, experts caution that translating findings from mice to humans is a significant challenge, and "strong scientific intent does not guarantee uniformly high rigor or translational success."

Despite the skepticism, Chinese companies like Lonvi are forging ahead, banking on the growing demand for life-extending treatments among the country's wealthy. The company's CEO, Yip Tszho, believes their grapeseed-based pills, combined with a healthy lifestyle, can help people live past 100 and up to 120 years old. While immortality may still be out of reach, these Chinese startups are determined to push the boundaries of human longevity.